Tobacco harm reduction: A call to address the ethical dilemmas

Nicotine and Tobacco Research

Volumn 4, Issue SUPPL. 2, 2002, Pages

  Fox, Brion J ^a   Cohen, Joanna E ^b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKING; DRUG INDUSTRY; ETHICS; HAZARD ASSESSMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; TOBACCO INDUSTRY;

EID: 0036958805     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/1462220021000032861     Document Type: Review

References (32)

1. Annas, G. J. (1997). Tobacco litigation as cancer prevention: dealing with the devil. New England Journal of Medicine, 336, 304-308.
2. Beauchamp, D. E., Steinbock, B. (1999). New ethics for the public's health. New York: Oxford University Press.
3. Bero, L., Barnes, D. E., Hanauer, P., Slade, J., Glantz, S. A. (1995). Lawyer control of the tobacco industry's external research program: The Brown and Williamson documents. Journal of the American Medical Association, 274, 241-247.
4. Bero, L. A., Galbraith, A., Rennie, D. (1992). The publication of sponsored symposiums in medical journals. New England Journal of Medicine, 327, 1135-1140.
5. Bodenheimer, T. (2000). Uneasy alliance: Clinical investigators and the pharmaceutical industry. New England Journal of Medicine, 342, 1539-1544.
6. Centers for Disease Control and Prevention. (1997, February). Guidance for collaboration with the private sector. Retrieved February 10, 2002, from http://www.cdc.gov/od/foia/policies/collabor.htm
7. Centers for Disease Control and Prevention. (1999). Best practices for comprehensive tobacco control programs. Atlanta, GA: Office on Smoking and Health.
8. Chapman, S., Borland, R., Scollo, M., Brownson, R. C., Dominello, A., Woodward, S. (1999). The impact of smoke-free workplaces on declining cigarette consumption in Australia and the United States. American Journal of Public Health, 89, 1018-1023.
9. Chapman, S., Shatenstein, S. (2001). The ethics of the cash register: Taking tobacco research dollars. Tobacco Control, 10, 1-2.
10. Coffield, A. B., Maciosek, M. V., McGinnis, J. M., Harris, J. R., Caldwell, M. B., Teutsch, S. M., Atkins, D., Richland, J. H., Haddix, A. (2001). Priorities among recommended clinical preventive services. American Journal of Preventive Medicine, 21, 1-9.
11. Cohen, J. E., Ashley, M. J., Goldstein, A. O., Ferrence, R., Brewster, J. M. (1999). Institutional addiction to tobacco. Tobacco Control, 8, 70-74.
12. Cohen, J. E. (2001). Universities and tobacco money: some universities are accomplices in the tobacco epidemic. British Medical Journal, 323, 1-2.
13. Davidoff, F., DeAngelis, C. D., Drazen, J. M., Hoey, J., Højgaard, L., Horton, R., Kotzin, S., Nicholls, M. G., Nylenna, M., Overbeke, A. J., Sox, H. C., Van Der Weyden, M. B., Wilkes, M. S. (2001). Sponsorship, authorship, and acountability. Journal of the American Medical Association, 286, 1232-1234.
14. Erickson, P. G. (1999). Introduction: The three phases of harm reduction. An examination of emerging concepts, methodologies, and critiques. Substance Use & Misuse, 34, 1-7.
15. Evans, W. N., Farrelly, M. C., Montgomery, E. (1999). Do workplace smoking bans reduce smoking? American Economic Review, 89, 728-747.
16. Fiore, M. C., Bailey, W. C., Cohen, S. J., et al. (2000). Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: Public Health Service.
17. Gardiner, P. (2001). The Philip Morris external research program; fig leaf optional. Burning Issues: TRDRP Newsletter, 4, 7-10.
18. Glasgow, R. E., Cummings, K. M., Hyland, A. (1997). Relationship of worksite smoking policy to changes in employee tobacco use: Findings from COMMIT. Tobacco Control, 6(Suppl 2), S44-S48.
19. Irvin, J. E., Brandon, T. H. (2000). The increasing recalcitrance of smokers in clinical trials. Nicotine & Tobacco Research, 2, 79-84.
20. Kass, N. E. (2001). An ethics framework for public health. American Journal of Public Health, 91, 1776-1782.
21. King, J., Yamey, G., Smith, R. (2000). For and against: Why journals should not publish articles funded by the tobacco industry. British Medical Journal, 321, 1074.
22. Kozlowski, L. T., Strasser, A. A., Giovino, G. A., Erickson, P. A., Terza, J. V. (2001). Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction. Tobacco Control, 10, 201-203.
23. Longo, W. E., Rigler, M. W., Slade, J. (1995). Crocidolite asbestos fibers in smoke from original Kent cigarettes. Cancer Research, 55, 2232-2235.
24. Mangham, C. (2001). Harm reduction and illegal drugs: the real debate. Canadian Journal of Public Health, 92, 204-205.
25. Mugford, S. (1992). Harm reduction: Does it lead where its proponents imagine? In N. Heather, A. Wodak, E. Nadelmann, & P. O'Hare (Eds.), Psychoactive drugs and harm reduction - from faith to science. London: Whurr Publishers.
26. National Cancer Institute. (2001). Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and Tobacco Control Monograph No. 13. (NIH Publication No. 02-5074). Retrieved July 10, 2002, from http://cancercontrol.cancer.gov/tcrb/monographs/13/
27. Saloojee, Y., & Dagli, E. (2000). Tobacco industry tactics for resisting public policy on health. Bulletin of the World Health Organization, 78, 902-910.
28. Shield, M. (2001). Policies and positions of other funding organizations on the funding controversy. Burning Issues: TRDRP Newsletter, 4, 2-4.
29. Stelfox, H. T., Chua, G., O'Rourke, K., & Detsky, A. S. (1998). Conflict of interest in the debate over calcium-channel antagonists. New England Journal of Medicine, 327, 101-106.
30. Stratton, K., Shetty, P., Wallace, R., & Bondurant, S. (Eds.). (2001). Clearing the smoke: Assessing the science base for tobacco harm reduction. Washington, DC: National Academy Press.
31. U. S. Department of Health and Human Services. (2000). Reducing tobacco use. A report of the Surgeon General. Washington, DC: U. S. Government Printing Office. Retrieved July 10, 2002, from http://www.cdc.gov/tobacco/sgr/sgr_2000.htm
32. Warner, K. E., Slade, J., Sweanor, D. T. (1997). The emerging market for long-term nicotine maintenance. Journal of the American Medical Association, 278, 1087-1092.